Graduate
Noel Donnelly MBA’97 was appointed chief financial officer of CNS-focused therapeutics company EIP Pharma. He previously worked at Takeda Pharmaceuticals, where he led a strategy and operations team, and spent more than 15 years at Shire, where he built responsibility and leadership in the company’s finance and research and development departments.